ABL mutations in late chronic phase chronic myeloid leukemia patients with up-front cytogenetic resistance to imatinib are associated with a greater likelihood of progression to blast crisis and shorter survival: a study by the GIMEMA Working Party o
article by Simona Soverini et al published 20 June 2005 in Journal of Clinical Oncology
Author/s
author: Simona Soverini, Elisabetta Abruzzese, Nicoletta Testoni, Giuseppe Saglio, Gianantonio Rosti, Fausto Castagnetti, Giovanni Martinelli, Michele Baccarani, Simona Luatti, Daniela Cilloni, Angela Poerio, Elena Trabacchi, Marilina Amabile, Fabrizio Pane, Barbara Giannini, Simona Bassi, Barbara Izzo, Milena Fava
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.